SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Fancy who wrote (5166)8/18/1998 9:40:00 AM
From: John F Beule  Read Replies (2) of 6136
 
Steve, you said: "DOW up 112 points and AGPH starts to come along very grudgingly. Maybe weekly scrip data was bad...I'll get it from my broker next time he calls."

How exactly does the DOW affect this and other small cap stocks?
That's like saying the Clinton trial affects my income, it has no relevance.

Let me help you muddle thru the stock price, we are in a time of high anxiety for investors. No one is going to place their money in a stock that has more money betting against it than for it (shorts vs longs). Until that sentiment changes, the stock will be unfairly (IMO) whipped by speculators. Viracept has already proven itself, another load of script data is irrelevant.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News